The GJB2 (connexin 26) gene, one of the major genes responsible for autosomal recessive deafness, has been investigated previously by a variety of techniques, including PCR-SSCP and sequencing of the entire gene for screening of unknown mutations, and allele-specific PCR, ASO, and PCR-mediated site-directed mutagenesis for the detection of the common mutation 35delG. Here, we present the development of a DGGE method for the characterization of the full spectrum of mutations in the GJB2 gene. The GJB2 cDNA and flanking sequences were amplified in three overlapping segments. We screened 26 Greek patients with prelingual, sensorineural deafness, where syndromic forms and environmental causes of deafness had been excluded. The 35delG mutation was detected in 28 chromosomes (53.8%), while another three sequence variations accounted for 7.6% of the alleles. The sequence variation R127H, previously described in a few Spanish and Balkan patients, was detected in two patients as the sole mutation. A novel sequence variation, K224Q, was identified as the sole mutation in one patient. Use of this approach may contribute to the full description of mutations in this important deafness gene.

Download full-text PDF

Source
http://dx.doi.org/10.1002/1098-1004(200007)16:1<7::AID-HUMU2>3.0.CO;2-ADOI Listing

Publication Analysis

Top Keywords

gjb2 connexin
8
connexin gene
8
greek patients
8
sensorineural deafness
8
sequence variation
8
sole mutation
8
mutation
5
gene
5
deafness
5
mutation analysis
4

Similar Publications

GJB2 encodes connexin 26 (Cx26), the most commonly mutated gene causing hereditary non-syndromic hearing loss. Cx26 is mainly expressed in supporting cells (SCs) and fibrocytes in the mammalian cochlea. Gene therapy is currently considered the most promising strategy for eradicating genetic diseases.

View Article and Find Full Text PDF

Auditory neuropathy spectrum disorder (ANSD) is often missed by standard hearing tests, accounting for up to 10% of hearing impairments (HI) and commonly linked to variants in 23 genes. We assessed 122 children with HI, including 102 with sensorineural hearing loss (SNHL) and 20 with ANSD. SNHL patients were genotyped for common variants using qPCR, while ANSD patients underwent whole exome sequencing, with variants analyzed across 249 genes.

View Article and Find Full Text PDF
Article Synopsis
  • Glioblastomas (GBM) are aggressive brain tumors with a poor outlook, prompting research into new biomarkers for potential treatments through analyzing mRNA-seq and clinical data from major databases.
  • A risk model was developed based on three ion channel-related genes, which indicated that higher risk scores correlate with increased immune cell infiltration and drug sensitivity for GBM.
  • Functional analyses and a regulatory network were constructed to explore gene interactions, revealing that two of the genes (GJB2 and KCNN4) were upregulated in the high-risk group, while another (KCNH6) was downregulated.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!